In the Spotlight - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

In the Spotlight

Pharmaceutical Technology
Volume 9, Issue 32, pp. 32

Tablet press produces scalable results


Flexitab tablet press (OYSTAR Manesty)
The fully automated, single-station "Flexitab" tablet press from OYSTAR Manesty (Fairfield, NJ) is designed to produce results similar to those of a rotary press. The device's two punches are each controlled by one pneumatic and one hydraulic cylinder, which help the unit achieve the same punch travel velocity and force as a rotary press. Scientists can "optimize a formulation with only a small amount of material," according to Nic Michel, vice-president of OYSTAR USA's process division.

In addition, the Flexitab machine produces single layer, bilayer, and trilayer tablets. Three hoppers are mounted on the press's die table. Each hopper has a pneumatically driven slide-feeder mechanism that automatically fills each tablet layer and compresses between each layer.

Michel adds that operators can set the unit's dwell time and punch displacement and store various compression profiles in the device's memory.

Platform refines data sharing


Nexus business platform (SupplyScape)
SupplyScape's (Woburn, MA) "Nexus" software is "a collaborative business platform that allows you to take advantage of granular product-serialization information," according to Peter Spellman, the company's senior vice-president of products and software as a service.

The application categorizes serialized information according to task or relationship profiles (e.g., the cold chain) that describe the kind of information to be shared and the format to present it in for each external partner. Spellman says the profiles contain data-sharing rules that allow firms to share only the information required to execute particular business processes.

Software helps users manage CAD models


SmartEngineer application (Pilgrim Software)
Pilgrim Software (Tampa, FL) recently introduced its "SmartEngineer" solution. The application allows users to check 3-D computer-aided design (CAD) models into Pilgrim's "SmartDoc" document-management repository. The SmartEngineer application also renders CAD mo-dels as "Acrobat" files, thus allowing them to be shared intelligently. Nikki Willett, Pilgrim's vice-president of marketing and regulatory affairs, says the SmartEngineer software reduces the need for licenses and training for CAD software for nonengineers.

The SmartEngineer product is intended to foster collaboration between pharmaceutical engineers, quality-assurance personnel, and manufacturing professionals throughout a product's life cycle. It enables an organization to establish version control for all its engineering drawings.

New Product Announcements may be sent to New Products Editor, Pharmaceutical Technology, 485 Route One South, Building F, First Floor, Iselin, NJ 08830, fax 732.596.0005,

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
27%
Breakthrough designations
9%
Protecting the supply chain
41%
Expedited reviews of drug submissions
9%
More stakeholder involvement
14%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology,
Click here